13
Participants
Start Date
May 31, 2016
Primary Completion Date
June 30, 2020
Study Completion Date
January 31, 2024
G207
Single dose of HSV-1 (G207) infused through catheters into region(s) of tumor defined by MRI
Children's of Alabama, Birmingham
Nationwide Children's Hospital, Columbus
Collaborators (1)
Food and Drug Administration (FDA)
FED
National Center for Advancing Translational Sciences of the National Institutes of Health
UNKNOWN
Cannonball Kids' Cancer Foundation
OTHER
Rally Foundation for Childhood Cancer Research
OTHER
Hyundai Hope On Wheels
OTHER
St. Baldrick's Foundation
OTHER
United States Department of Defense
FED
The Andrew McDonough B+ Foundation
OTHER
Kaul Pediatric Research Institute
UNKNOWN
University of Alabama at Birmingham
OTHER
Memorial Sloan Kettering Cancer Center
OTHER
Kelsie's Crew
UNKNOWN
Eli's Block Party Childhood Cancer Foundation
UNKNOWN
Eli Jackson Foundation
UNKNOWN
Jaxon's F.R.O.G. Foundation
UNKNOWN
Battle for a Cure Foundation
UNKNOWN
Sandcastle Kids
UNKNOWN
Gregory K. Friedman, MD
OTHER